Copyright © 1996 by the European Society of Cardiology.
© 1996 The European Society of Cardiology
Total Ischaemic Burden European Trial (TIBET)
Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina

*University of Glasgow Glasgow, U.K.
Royal Brompton Hospital London, U.K.
Received 4 September 1995; accepted 20 September 1995.
Correspondence: Professor H. J. Dargie, West Medical Building. University of Glasgow, Glasgow G12 8QQ, U.K.
Abstract
OBJECTIVES: To study the relationship between presence or absence of ischaemic events on Holter monitoring and occurrence of a hard or hard+soft endpoint.
DESIGN: A randomized double-blind parallel group study of atenolol, nifedipine and their combination, with ambulatory monitoring off-treatment and after 6 weeks of randomized treatment and prospective follow-up of 2 years on average.
SETTING: Europe.
SUBJECTS: 682 men and women with a diagnosis of chronic stable angina and who were not being considered for surgery.
MAIN OUTCOME: Hard endpoints were cardiac death, nonfatal myocardial infarction and unstable angina; soft endpoints were coronary artery bypass surgery, coronary angioplasty and treatment failure.
RESULTS: The study showed no evidence of an association between the presence, frequency or total duration of ischaemic events on Holter monitoring, either on or off treatment, and the main outcome measures. There was a non-significant trend to a lower rate of hard endpoints in the group receiving combination therapy. Compliance, as measured by withdrawal from trial medication, was clearly poorest in the nifedipine group with similar with drawal rates in the atenolol and combination therapy groups.
CONCLUSION: The recording of ischaemic events in 48 h Holter monitoring failed to predict hard or hard+soft endpoints in patients with chronic stable angina.
Key Words: Ischaemia Holter monitoring beta-blocker calcium channel blocker
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Crea, P. G. Camici, R. De Caterina, and G. A. Lanza CHAPTER 17 Chronic Ischaemic Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Erne, A. W. Schoenenberger, D. Burckhardt, M. Zuber, W. Kiowski, P. T. Buser, P. Dubach, T. J. Resink, and M. Pfisterer Effects of Percutaneous Coronary Interventions in Silent Ischemia After Myocardial Infarction: The SWISSI II Randomized Controlled Trial JAMA, May 9, 2007; 297(18): 1985 - 1991. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Sutton, J. E. Otterstad, B.-A. Kirwan, Z. Voko, S. de Brouwer, J. Lubsen, P. A. Poole-Wilson, and ACTION (A Coronary disease Trial Investigating Out The development of heart failure in patients with stable angina pectoris Eur J Heart Fail, March 1, 2007; 9(3): 234 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Stone, N. A. Gratsiansky, A. Blokhin, I-Z. Huang, L. Meng, and for the ERICA Investigators Antianginal Efficacy of Ranolazine When Added to Treatment With Amlodipine: The ERICA (Efficacy of Ranolazine in Chronic Angina) Trial J. Am. Coll. Cardiol., August 1, 2006; 48(3): 566 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, K. Fox, M. A. A. Garcia, D. Ardissino, P. Buszman, P. G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur. Heart J., June 1, 2006; 27(11): 1341 - 1381. [Full Text] [PDF] |
||||
![]() |
F. Enseleit and F. Duru Long-term continuous external electrocardiographic recording: a review. Europace, April 1, 2006; 8(4): 255 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
D A Mulcahy The return of silent ischaemia? Not really Heart, October 1, 2005; 91(10): 1249 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Daly, F. Clemens, J. L. L. Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, et al. The initial management of stable angina in Europe, from the Euro Heart Survey: A description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina Eur. Heart J., May 2, 2005; 26(10): 1011 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L Eastaugh, M. J Calvert, and N. Freemantle Highlighting the need for better patient care in stable angina: results of the international Angina Treatment Patterns (ATP) Survey in 7074 patients Fam. Pract., February 1, 2005; 22(1): 43 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
Task Force Members, J. Lopez-Sendo, K. Swedberg, J. McMurray, J. Tamargo, A. P. Maggioni, H. Dargie, M. Tendera, F. Waagstein, J. Kjekshus, et al. Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology Eur. Heart J., August 1, 2004; 25(15): 1341 - 1362. [Full Text] [PDF] |
||||
![]() |
U. Thadani Current Medical Management of Chronic Stable Angina Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S11 - S29. [Abstract] [PDF] |
||||
![]() |
P. F. Cohn, K. M. Fox, and C. Daly Silent Myocardial Ischemia Circulation, September 9, 2003; 108(10): 1263 - 1277. [Full Text] [PDF] |
||||
![]() |
C Daly, J Norrie, D.L Murdoch, I Ford, H.J Dargie, K Fox, and for the TIBET study group The value of routine non-invasive tests to predict clinical outcome in stable angina Eur. Heart J., March 2, 2003; 24(6): 532 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Klein Treatment patterns in stable angina: objectives and reality Eur. Heart J. Suppl., November 1, 2001; 3(suppl_O): O8 - O11. [Abstract] [PDF] |
||||
![]() |
S. D. Fihn, S. V. Williams, J. Daley, and R. J. Gibbons Guidelines for the Management of Patients with Chronic Stable Angina: Treatment Ann Intern Med, October 16, 2001; 135(8_Part_1): 616 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E Newby and K. A A Fox Unstable angina: the first 48 hours and later in-hospital management Br. Med. Bull., October 1, 2001; 59(1): 69 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
The IONA Study Group Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management Heart, June 1, 2001; 85(6): 9e - 9. [Abstract] [Full Text] |
||||
![]() |
M. Eccles, N. Rousseau, P. Adams, and L. Thomas Evidence-based guideline for the primary care management of stable angina Fam. Pract., April 1, 2001; 18(2): 217 - 222. [Full Text] [PDF] |
||||
![]() |
M J A Williams, C J S Low, G T Wilkins, and R A H Stewart Randomised comparison of the effects of nicardipine and esmolol on coronary artery wall stress: implications for the risk of plaque rupture Heart, October 1, 2000; 84(4): 377 - 382. [Abstract] [Full Text] |
||||
![]() |
L Forslund, P Hjemdahl, C Held, I Bjorkander, S.V Eriksson, U Brodin, and N Rehnqvist Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from The Angina Prognosis Study In Stockholm (APSIS) Eur. Heart J., June 1, 2000; 21(11): 901 - 910. [Abstract] [PDF] |
||||
![]() |
M. H. Crawford, S. J. Bernstein, P. C. Deedwania, J. P. DiMarco, K. J. Ferrick, A. Garson Jr, L. A. Green, H. L. Greene, M. J. Silka, P. H. Stone, et al. ACC/AHA guidelines for ambulatory electrocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology J. Am. Coll. Cardiol., September 1, 1999; 34(3): 912 - 948. [Full Text] [PDF] |
||||
![]() |
P. Abrahamsson, K. Andersen, P. Eriksson, and M. Dellborg Prognostic value of maximum ST-vector magnitude during the first 24h of vectorcardiographic monitoring in patients with unstable angina pectoris Eur. Heart J., August 2, 1999; 20(16): 1166 - 1174. [Abstract] [PDF] |
||||
![]() |
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197. [Full Text] [PDF] |
||||
![]() |
P. A. Heidenreich, K. M. McDonald, T. Hastie, B. Fadel, V. Hagan, B. K. Lee, and M. A. Hlatky Meta-analysis of Trials Comparing {beta}-Blockers, Calcium Antagonists, and Nitrates for Stable Angina JAMA, May 26, 1999; 281(20): 1927 - 1936. [Abstract] [Full Text] [PDF] |
||||
![]() |
D de Bono Investigation and management of stable angina: revised guidelines 1998 Heart, May 1, 1999; 81(5): 546 - 555. [Full Text] |
||||
![]() |
W. B. Stason, C. H. Schmid, D. Niedzwiecki, G. W. Whiting, J.-F. Caubet, D. Cory, D. Luo, S. D. Ross, and T. C. Chalmers Safety of Nifedipine in Angina Pectoris : A Meta-Analysis Hypertension, January 1, 1999; 33(1): 24 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Pepine, E. Handberg-Thurmond, R. G. Marks, M. Conlon, R. Cooper-Dehoff, P. Volkers, P. Zellig, and for The INVEST Investigators Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1228 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Quyyumi and D. Mulcahy Can Ambulatory Monitoring Identify High-Risk Patients With Stable Coronary Artery Disease?-Reply JAMA, June 11, 1997; 277(22): 1760 - 1761. [Abstract] [PDF] |
||||
![]() |
D. Mulcahy, S. Husain, G. Zalos, A. Rehman, N. P. Andrews, W. H. Schenke, N. L. Geller, and A. A. Quyyumi Ischemia During Ambulatory Monitoring as a Prognostic Indicator in Patients With Stable Coronary Artery Disease JAMA, January 22, 1997; 277(4): 318 - 324. [Abstract] [PDF] |
||||













